223 related articles for article (PubMed ID: 8624711)
61. Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotide probe effects in mice and rats.
Hadjimarkou MM; Singh A; Kandov Y; Israel Y; Pan YX; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2004 Dec; 311(3):1188-202. PubMed ID: 15333676
[TBL] [Abstract][Full Text] [Related]
62. A bi-directional mu-opioid-opioid connection between the nucleus of the accumbens shell and the central nucleus of the amygdala in the rat.
Kim EM; Quinn JG; Levine AS; O'Hare E
Brain Res; 2004 Dec; 1029(1):135-9. PubMed ID: 15533326
[TBL] [Abstract][Full Text] [Related]
63. Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: comparison with alteration of [3H]DAMGO binding to rat brain sections.
Martin TJ; DeMontis MG; Kim SA; Sizemore GM; Dworkin SI; Smith JE
Drug Alcohol Depend; 1998 Oct; 52(2):135-47. PubMed ID: 9800143
[TBL] [Abstract][Full Text] [Related]
64. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats.
Cole JL; Berman N; Bodnar RJ
Peptides; 1997; 18(8):1201-7. PubMed ID: 9396062
[TBL] [Abstract][Full Text] [Related]
66. Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake.
Schlosburg JE; Whitfield TW; Park PE; Crawford EF; George O; Vendruscolo LF; Koob GF
J Neurosci; 2013 Dec; 33(49):19384-92. PubMed ID: 24305833
[TBL] [Abstract][Full Text] [Related]
67. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens.
Zhang M; Kelley AE
Psychopharmacology (Berl); 2002 Feb; 159(4):415-23. PubMed ID: 11823894
[TBL] [Abstract][Full Text] [Related]
68. Modulation of humoral immune response by central administration of leucine-enkephalin: effects of mu, delta and kappa opioid receptor antagonists.
Radulović J; Mancev Z; Stanojević S; Vasiljević T; Kovacević-Jovanović V; Pesić G
J Neuroimmunol; 1996 Apr; 65(2):155-61. PubMed ID: 8964897
[TBL] [Abstract][Full Text] [Related]
69. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.
Xiong W; Yu LC
Neurosci Lett; 2006 May; 399(1-2):167-70. PubMed ID: 16490317
[TBL] [Abstract][Full Text] [Related]
70. Mediation of insulin hyperphagia by specific central opiate receptor antagonists.
Beczkowska IW; Bodnar RJ
Brain Res; 1991 May; 547(2):315-8. PubMed ID: 1653080
[TBL] [Abstract][Full Text] [Related]
71. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
72. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
73. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.
Broadbear JH; Negus SS; Butelman ER; de Costa BR; Woods JH
Psychopharmacology (Berl); 1994 Jul; 115(3):311-9. PubMed ID: 7871070
[TBL] [Abstract][Full Text] [Related]
74. κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats.
Nealey KA; Smith AW; Davis SM; Smith DG; Walker BM
Neuropharmacology; 2011; 61(1-2):35-42. PubMed ID: 21338616
[TBL] [Abstract][Full Text] [Related]
75. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats.
Gu XL; Yu LC
J Pain; 2007 Jan; 8(1):85-90. PubMed ID: 17097925
[TBL] [Abstract][Full Text] [Related]
76. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
77. Effects of beta-funaltrexamine on ingestive behaviors in the rat.
Ukai M; Holtzman SG
Eur J Pharmacol; 1988 Aug; 153(2-3):161-5. PubMed ID: 2846315
[TBL] [Abstract][Full Text] [Related]
78. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
79. Opioid receptors and acetaminophen (paracetamol).
Raffa RB; Walker EA; Sterious SN
Eur J Pharmacol; 2004 Oct; 503(1-3):209-10. PubMed ID: 15496316
[TBL] [Abstract][Full Text] [Related]
80. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
